{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T07:44:04Z","timestamp":1786175044545,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fujian Provincial Joint Fund for Science and Technology Innovation Project","award":["2025Y9444"],"award-info":[{"award-number":["2025Y9444"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12570-8","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T07:22:59Z","timestamp":1786173779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in paclitaxel-mediated remodeling of the gastric cancer immune microenvironment and sensitization to immune checkpoint inhibitors via cGAS-STING pathway activation triggered by mtDNA release: challenges and translational perspectives"],"prefix":"10.1007","volume":"53","author":[{"given":"Chu-Ying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zun-Long","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"12570_CR1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3390\/cancers16030560","volume":"16","author":"V Akkanapally","year":"2024","unstructured":"Akkanapally V, Bai XF, Basu S (2024) Therapeutic Immunomodulation in Gastric Cancer. Cancers (Basel) 16:560. https:\/\/doi.org\/10.3390\/cancers16030560","journal-title":"Cancers (Basel)"},{"key":"12570_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/10815589251348919","volume":"73","author":"D Luo","year":"2025","unstructured":"Luo D, Liu Y, Huang L (2025) Advanced therapies for stomach cancer. J Investig Med 73:673\u2013684. https:\/\/doi.org\/10.1177\/10815589251348919","journal-title":"J Investig Med"},{"key":"12570_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.46439\/cancerbiology.2.031","volume":"2","author":"ER Smith","year":"2021","unstructured":"Smith ER, Xu XX (2021) Breaking malignant nuclei as a non-mitotic mechanism of taxol\/paclitaxel. J Cancer Biol 2:86\u201393. https:\/\/doi.org\/10.46439\/cancerbiology.2.031","journal-title":"J Cancer Biol"},{"key":"12570_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O et al (2017) Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol 17:97\u2013111. https:\/\/doi.org\/10.1038\/nri.2016.107","journal-title":"Nat Rev Immunol"},{"key":"12570_CR5","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050\u20131059. https:\/\/doi.org\/10.1038\/nm1622","journal-title":"Nat Med"},{"key":"12570_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/2326-6066.CIR-17-0650","volume":"6","author":"CW Wanderley","year":"2018","unstructured":"Wanderley CW, Col\u00f3n DF, Luiz JPM et al (2018) Paclitaxel reduces tumor growth by promoting tumor-infiltrating lymphocytes and enhancing the antitumor immune response. Cancer Immunol Res 6:1291\u20131305. https:\/\/doi.org\/10.1158\/2326-6066.CIR-17-0650","journal-title":"Cancer Immunol Res"},{"key":"12570_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/1120009X.2022.2157618","volume":"35","author":"J Xu","year":"2023","unstructured":"Xu J, Xu Y, Ye G et al (2023) LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis. J Chemother 35:527\u2013538. https:\/\/doi.org\/10.1080\/1120009X.2022.2157618","journal-title":"J Chemother"},{"key":"12570_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/1120009X.2023.2203606","volume":"36","author":"W Xiang","year":"2024","unstructured":"Xiang W, Zhang B, Li H (2024) LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis. J Chemother 36:49\u201360. https:\/\/doi.org\/10.1080\/1120009X.2023.2203606","journal-title":"J Chemother"},{"key":"12570_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SWG Tait","year":"2010","unstructured":"Tait SWG, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11:621\u2013632. https:\/\/doi.org\/10.1038\/nrm2952","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12570_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.yjmcc.2009.02.021","volume":"46","author":"AP Halestrap","year":"2009","unstructured":"Halestrap AP (2009) What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 46:821\u2013831. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.02.021","journal-title":"J Mol Cell Cardiol"},{"key":"12570_CR11","doi-asserted-by":"publisher","first-page":"eaao6047","DOI":"10.1126\/science.aao6047","volume":"359","author":"K McArthur","year":"2018","unstructured":"McArthur K, Whitehead LW, Heddleston JM et al (2018) BAK\/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science 359:eaao6047. https:\/\/doi.org\/10.1126\/science.aao6047","journal-title":"Science"},{"key":"12570_CR12","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen Q, Sun L, Chen ZJ (2016) Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat Immunol 17:1142\u20131149. https:\/\/doi.org\/10.1038\/ni.3558","journal-title":"Nat Immunol"},{"key":"12570_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc1317","volume":"4","author":"MA Jordan","year":"2004","unstructured":"Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253\u2013265. https:\/\/doi.org\/10.1038\/nrc1317","journal-title":"Nat Rev Cancer"},{"key":"12570_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M et al (2015) Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520:553\u2013557. https:\/\/doi.org\/10.1038\/nature14156","journal-title":"Nature"},{"key":"12570_CR15","doi-asserted-by":"publisher","first-page":"e99238","DOI":"10.15252\/embj.201899238","volume":"37","author":"JS Riley","year":"2018","unstructured":"Riley JS, Quarato G, Cloix C et al (2018) Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis. EMBO J 37:e99238. https:\/\/doi.org\/10.15252\/embj.201899238","journal-title":"EMBO J"},{"key":"12570_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nature03317","volume":"434","author":"T Nakagawa","year":"2005","unstructured":"Nakagawa T, Shimizu S, Watanabe T et al (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434:652\u2013658. https:\/\/doi.org\/10.1038\/nature03317","journal-title":"Nature"},{"key":"12570_CR17","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.cell.2012.05.014","volume":"149","author":"AV Vaseva","year":"2012","unstructured":"Vaseva AV, Marchenko ND, Ji K et al (2012) p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149:1536\u20131548. https:\/\/doi.org\/10.1016\/j.cell.2012.05.014","journal-title":"Cell"},{"key":"12570_CR18","doi-asserted-by":"publisher","first-page":"e020587","DOI":"10.1161\/JAHA.120.020587","volume":"10","author":"JZ Zhang","year":"2021","unstructured":"Zhang JZ, Liu Z, Liu J et al (2021) Mitochondrial DNA release mediated by the mitochondrial permeability transition pore contributes to myocardial ischemia\/reperfusion injury. J Am Heart Assoc 10:e020587. https:\/\/doi.org\/10.1161\/JAHA.120.020587","journal-title":"J Am Heart Assoc"},{"key":"12570_CR19","doi-asserted-by":"publisher","first-page":"e70793","DOI":"10.1002\/jbt.70793","volume":"40","author":"H Salati Momeni","year":"2026","unstructured":"Salati Momeni H, Tabibzadeh S, Niapour A (2026) Carvedilol Upregulates Inflammatory Factors to Enhance Paclitaxel Sensitivity in Paclitaxel-Resistant Gastric Cancer AGS Cells: Influences on \u03b2-Arrestin-2\/cGAS-STING Axis. J Biochem Mol Toxicol 40:e70793. https:\/\/doi.org\/10.1002\/jbt.70793","journal-title":"J Biochem Mol Toxicol"},{"key":"12570_CR20","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","volume":"153","author":"P Gao","year":"2013","unstructured":"Gao P, Ascano M, Wu Y et al (2013) Cyclic [G(2\u2032,5\u2032)pA(3\u2032,5\u2032)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153:1094\u20131107. https:\/\/doi.org\/10.1016\/j.cell.2013.04.046","journal-title":"Cell"},{"key":"12570_CR21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674\u2013678. https:\/\/doi.org\/10.1038\/nature07317","journal-title":"Nature"},{"key":"12570_CR22","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1084\/jem.20101159","volume":"208","author":"MB Fuertes","year":"2011","unstructured":"Fuertes MB, Kacha AK, Kline J et al (2011) Host type I IFN signals are required for antitumor CD8\u2009+\u2009T cell responses through CD8\u03b1\u2009+\u2009dendritic cells. J Exp Med 208:2005\u20132016. https:\/\/doi.org\/10.1084\/jem.20101159","journal-title":"J Exp Med"},{"key":"12570_CR23","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","volume":"69","author":"H Harlin","year":"2009","unstructured":"Harlin H, Meng Y, Peterson AC et al (2009) Chemokine expression in melanoma metastases associated with CD8\u2009+\u2009T-cell recruitment. Cancer Res 69:3077\u20133085. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2281","journal-title":"Cancer Res"},{"key":"12570_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.celrep.2015.12.029","volume":"14","author":"T Xia","year":"2016","unstructured":"Xia T, Konno H, Ahn J et al (2016) Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep 14:282\u2013297. https:\/\/doi.org\/10.1016\/j.celrep.2015.12.029","journal-title":"Cell Rep"},{"key":"12570_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-021-01385-9","volume":"20","author":"T Li","year":"2021","unstructured":"Li T, Wang Y, Liu X et al (2021) Paclitaxel-induced mitochondrial DNA release activates cGAS-STING pathway to enhance antitumor immunity in colorectal cancer. Mol Cancer 20:100. https:\/\/doi.org\/10.1186\/s12943-021-01385-9","journal-title":"Mol Cancer"},{"key":"12570_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M et al (2014) STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41:843\u2013852. https:\/\/doi.org\/10.1016\/j.immuni.2014.10.019","journal-title":"Immunity"},{"key":"12570_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12967-020-02535-1","volume":"18","author":"H Wang","year":"2020","unstructured":"Wang H, Hu S, Chen X et al (2020) cGAS-STING pathway mediates paclitaxel-induced chemokine secretion in gastric cancer cells. J Transl Med 18:356. https:\/\/doi.org\/10.1186\/s12967-020-02535-1","journal-title":"J Transl Med"},{"key":"12570_CR28","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.4049\/jimmunol.1401203","volume":"193","author":"AR Lam","year":"2014","unstructured":"Lam AR, Le Bert N, Ho SSW et al (2014) RIG-I and STING are essential for the cGAS-STING-dependent inflammatory response to cytosolic DNA. J Immunol 193:3206\u20133214. https:\/\/doi.org\/10.4049\/jimmunol.1401203","journal-title":"J Immunol"},{"key":"12570_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger S, Bao R, Gajewski TF (2015) Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature 523:231\u2013235. https:\/\/doi.org\/10.1038\/nature14404","journal-title":"Nature"},{"key":"12570_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","volume":"348","author":"JA Joyce","year":"2015","unstructured":"Joyce JA, Fearon DT (2015) T cell exclusion, immune privilege, and the tumor microenvironment. Science 348:74\u201380. https:\/\/doi.org\/10.1126\/science.aaa6204","journal-title":"Science"},{"key":"12570_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri2216","volume":"8","author":"L Zitvogel","year":"2008","unstructured":"Zitvogel L, Apetoh L, Ghiringhelli F et al (2008) Immunological aspects of cancer chemotherapy. Nat Rev Immunol 8:59\u201373. https:\/\/doi.org\/10.1038\/nri2216","journal-title":"Nat Rev Immunol"},{"key":"12570_CR32","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen L, Han X (2015) Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest 125:3384\u20133391. https:\/\/doi.org\/10.1172\/JCI80011","journal-title":"J Clin Invest"},{"key":"12570_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162\u2013174. https:\/\/doi.org\/10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"key":"12570_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP (2015) The future of immune checkpoint therapy. Science 348:56\u201361. https:\/\/doi.org\/10.1126\/science.aaa8172","journal-title":"Science"},{"key":"12570_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","volume":"13","author":"MJ Smyth","year":"2016","unstructured":"Smyth MJ, Ngiow SF, Ribas A et al (2016) Combination cancer immunotherapies tailored to the tumour microenvironment. Nat Rev Clin Oncol 13:143\u2013158. https:\/\/doi.org\/10.1038\/nrclinonc.2015.209","journal-title":"Nat Rev Clin Oncol"},{"key":"12570_CR36","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.2147\/DDDT.S455248","volume":"18","author":"L Shen","year":"2024","unstructured":"Shen L, Chen Z, Zhang Z et al (2024) Clinical Efficacy of Taxol Plus Platinum (TP) Chemotherapy Combined with Delayed Administration of PD-1 Inhibitors in Patients with Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective Study. Drug Des Devel Ther 18:2761\u20132773. https:\/\/doi.org\/10.2147\/DDDT.S455248","journal-title":"Drug Des Devel Ther"},{"key":"12570_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00432-021-03819-3","volume":"148","author":"J Wang","year":"2022","unstructured":"Wang J, Li D, Li H et al (2022) Paclitaxel enhances the antitumor activity of anti-PD-1 antibody by remodeling the immune microenvironment in a mouse model of gastric cancer. J Cancer Res Clin Oncol 148:141\u2013152. https:\/\/doi.org\/10.1007\/s00432-021-03819-3","journal-title":"J Cancer Res Clin Oncol"},{"key":"12570_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2026.01.005","author":"YX Chen","year":"2026","unstructured":"Chen YX, Jin Y, Chen YK et al (2026) Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2026.01.005","journal-title":"Ann Oncol"},{"key":"12570_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.20892\/j.issn.2095-3941.2025.0360","volume":"23","author":"Y Bi","year":"2026","unstructured":"Bi Y, Wei S, Zhang Z et al (2026) VDAC1 protein derived from extracellular vesicles promotes paclitaxel resistance in gastric cancer through autophagy and mitophagy. Cancer Biol Med 23:252\u2013275. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2025.0360","journal-title":"Cancer Biol Med"},{"key":"12570_CR40","doi-asserted-by":"publisher","first-page":"1563300","DOI":"10.3389\/fimmu.2025.1563300","volume":"16","author":"W Ren","year":"2025","unstructured":"Ren W, Zhang H, Li Y et al (2025) Efficacy and safety of PD-1\/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis. Front Immunol 16:1563300. https:\/\/doi.org\/10.3389\/fimmu.2025.1563300","journal-title":"Front Immunol"},{"key":"12570_CR41","doi-asserted-by":"publisher","first-page":"6080","DOI":"10.1038\/s41598-023-33038-w","volume":"13","author":"R Ma","year":"2023","unstructured":"Ma R, Yuan D, Mo C et al (2023) Factors affecting the ORR after neoadjuvant therapy of TP regimen combined with PD-1 inhibitors for esophageal cancer. Sci Rep 13:6080. https:\/\/doi.org\/10.1038\/s41598-023-33038-w","journal-title":"Sci Rep"},{"key":"12570_CR42","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/S1470-2045(20)30478-4","volume":"21","author":"A Fumagalli","year":"2020","unstructured":"Fumagalli A, D\u2019Ugo D (2020) Weekly paclitaxel in gastric cancer. Lancet Oncol 21:1123\u20131132. https:\/\/doi.org\/10.1016\/S1470-2045(20)30478-4","journal-title":"Lancet Oncol"},{"key":"12570_CR43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman HJ, Zhang H (2021) Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov 20:689\u2013709. https:\/\/doi.org\/10.1038\/s41573-021-00233-1","journal-title":"Nat Rev Drug Discov"},{"key":"12570_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1084\/jem.193.4.509","volume":"193","author":"E Jacotot","year":"2001","unstructured":"Jacotot E, Ferri KF, El Hamel C et al (2001) Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2. J Exp Med 193:509\u2013520. https:\/\/doi.org\/10.1084\/jem.193.4.509","journal-title":"J Exp Med"},{"key":"12570_CR45","doi-asserted-by":"publisher","first-page":"783317","DOI":"10.3389\/fphar.2021.783317","volume":"12","author":"M Sui","year":"2021","unstructured":"Sui M, Yang H, Guo M et al (2021) Cajanol Sensitizes A2780\/Taxol Cells to Paclitaxel by Inhibiting the PI3K\/Akt\/NF-\u03baB Signaling Pathway. Front Pharmacol 12:783317. https:\/\/doi.org\/10.3389\/fphar.2021.783317","journal-title":"Front Pharmacol"},{"key":"12570_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s13402-021-00645-6","volume":"45","author":"A Aytatli","year":"2022","unstructured":"Aytatli A, Barlak N, Sanli F et al (2022) AZD4547 targets the FGFR\/Akt\/SOX2 axis to overcome paclitaxel resistance in head and neck cancer. Cell Oncol (Dordr) 45:41\u201356. https:\/\/doi.org\/10.1007\/s13402-021-00645-6","journal-title":"Cell Oncol (Dordr)"},{"key":"12570_CR47","doi-asserted-by":"publisher","first-page":"213824","DOI":"10.1016\/j.bioadv.2024.213824","volume":"159","author":"R Chen","year":"2024","unstructured":"Chen R, Liu E, Fang Y et al (2024) Naturally sourced amphiphilic peptides as paclitaxel vehicles for breast cancer treatment. Biomater Adv 159:213824. https:\/\/doi.org\/10.1016\/j.bioadv.2024.213824","journal-title":"Biomater Adv"},{"key":"12570_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12032-021-01606-7","volume":"39","author":"N Dastmalchi","year":"2021","unstructured":"Dastmalchi N, Azarbarzin S, Safaralizadeh R et al (2021) The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer. Med Oncol 39:9. https:\/\/doi.org\/10.1007\/s12032-021-01606-7","journal-title":"Med Oncol"},{"key":"12570_CR49","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s11033-021-06193-4","volume":"48","author":"N Dastmalchi","year":"2021","unstructured":"Dastmalchi N, Safaralizadeh R, Hosseinpourfeizi MA et al (2021) MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. Mol Biol Rep 48:1345\u20131357. https:\/\/doi.org\/10.1007\/s11033-021-06193-4","journal-title":"Mol Biol Rep"},{"key":"12570_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R et al (2020) CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer 19:43. https:\/\/doi.org\/10.1186\/s12943-020-01168-8","journal-title":"Mol Cancer"},{"key":"12570_CR51","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123:309\u2013314. https:\/\/doi.org\/10.1126\/science.123.3191.309","journal-title":"Science"},{"key":"12570_CR52","doi-asserted-by":"publisher","unstructured":"Tu S, Wang XD, Yang H (2026) Nanomedicine in precision treatment of gastric cancer: current clinical landscape. Mol Biol Rep 53. https:\/\/doi.org\/10.1007\/s11033-026-12068-3","DOI":"10.1007\/s11033-026-12068-3"},{"key":"12570_CR53","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1172\/JCI67230","volume":"123","author":"GL Semenza","year":"2013","unstructured":"Semenza GL (2013) HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 123:3664\u20133671. https:\/\/doi.org\/10.1172\/JCI67230","journal-title":"J Clin Invest"},{"key":"12570_CR54","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/fcp.12759","volume":"36","author":"X Yang","year":"2022","unstructured":"Yang X, Liu Z, Yin X et al (2022) Inhibition MNK-eIF4E-\u03b2-catenin preferentially sensitizes gastric cancer to chemotherapy. Fundam Clin Pharmacol 36:712\u2013720. https:\/\/doi.org\/10.1111\/fcp.12759","journal-title":"Fundam Clin Pharmacol"},{"key":"12570_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00894-020-04400-w","volume":"26","author":"L Zhu","year":"2020","unstructured":"Zhu L, Zhang C, L\u00fc X et al (2020) Binding modes of cabazitaxel with the different human \u03b2-tubulin isotypes: DFT and MD studies. J Mol Model 26:162. https:\/\/doi.org\/10.1007\/s00894-020-04400-w","journal-title":"J Mol Model"},{"key":"12570_CR56","doi-asserted-by":"publisher","first-page":"103708","DOI":"10.1016\/j.xphs.2025.103708","volume":"114","author":"L Xu","year":"2025","unstructured":"Xu L, Schaefer KG, King GM et al (2025) Insights into interactions between taxanes and P-glycoprotein using biophysical and in silico methods. J Pharm Sci 114:103708. https:\/\/doi.org\/10.1016\/j.xphs.2025.103708","journal-title":"J Pharm Sci"},{"key":"12570_CR57","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S et al (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21:548\u2013569. https:\/\/doi.org\/10.1038\/s41577-021-00524-z","journal-title":"Nat Rev Immunol"},{"key":"12570_CR58","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.3390\/cancers13112695","volume":"13","author":"A Amouzegar","year":"2021","unstructured":"Amouzegar A, Chelvanambi M, Filderman JN et al (2021) STING agonists as cancer therapeutics. Cancers (Basel) 13:2695. https:\/\/doi.org\/10.3390\/cancers13112695","journal-title":"Cancers (Basel)"},{"key":"12570_CR59","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature03434","volume":"434","author":"CP Baines","year":"2005","unstructured":"Baines CP, Kaiser RA, Purcell NH et al (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434:658\u2013662. https:\/\/doi.org\/10.1038\/nature03434","journal-title":"Nature"},{"key":"12570_CR60","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature14893","volume":"524","author":"M Lazarou","year":"2015","unstructured":"Lazarou M, Sliter DA, Kane LA et al (2015) The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524:309\u2013314. https:\/\/doi.org\/10.1038\/nature14893","journal-title":"Nature"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12570-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12570-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T07:23:00Z","timestamp":1786173780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12570-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12570"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12570-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1368"}}